Mortality after incident cancer in people with and without type 2 diabetes: impact of metformin on survival - Wikidata - wikimedia - TriplyDB

Mortality after incident cancer in people with and without type 2 diabetes: impact of metformin on survival

Mortality after incident cancer in people with and without type 2 diabetes: impact of metformin on survival

http://www.wikidata.org/entity/Q35688186

about

Network-based analysis of comorbidities risk during an infection: SARS and HIV case studies Validating drug repurposing signals using electronic health records: a case study of metformin associated with reduced cancer mortality Metformin use improves survival of diabetic liver cancer patients: systematic review and meta-analysis Unexploited Antineoplastic Effects of Commercially Available Anti-Diabetic Drugs Repurposing metformin for cancer treatment: current clinical studies Metformin Is Associated With Slightly Reduced Risk of Colorectal Cancer and Moderate Survival Benefits in Diabetes Mellitus: A Meta-Analysis Obesity and cancer: mechanistic insights from transdisciplinary studies Targeting LKB1 in cancer - exposing and exploiting vulnerabilities The links between insulin resistance, diabetes, and cancer Metformin and the risk of cancer: time-related biases in observational studies The association between type 2 diabetes mellitus and women cancer: the epidemiological evidences and putative mechanisms Diabetes and mortality in patients with prostate cancer: a meta-analysis Dissecting the Dual Role of AMPK in Cancer: From Experimental to Human Studies Metformin in obesity, cancer and aging: addressing controversies Effect of metformin on cancer risk and treatment outcome of prostate cancer: a meta-analysis of epidemiological observational studies Modulation of cell metabolic pathways and oxidative stress signaling contribute to acquired melphalan resistance in multiple myeloma cells BET bromodomain proteins and epigenetic regulation of inflammation: implications for type 2 diabetes and breast cancer.Obesity and cancer pathogenesis.Obesity and overfeeding affecting both tumor and systemic metabolism activates the progesterone receptor to contribute to postmenopausal breast cancer Association between diabetes or antidiabetic therapy and lung cancer: A meta-analysis Use of metformin and survival of diabetic women with breast cancer Metformin is associated with survival benefit in pancreatic cancer patients with diabetes: a systematic review and meta-analysis.Metformin and prostate cancer: reduced development of castration-resistant disease and prostate cancer mortality.Effects of prolonged exposure to low dose metformin in thyroid cancer cell lines.Diabetes medications and cancer risk: review of the literature Hiding in plain view: the potential for commonly used drugs to reduce breast cancer mortality.Metabolic syndrome in breast cancer.Diabetes and cancer II: role of diabetes medications and influence of shared risk factors.Metformin and cancer risk and mortality: a systematic review and meta-analysis taking into account biases and confounders.Metformin and cancer.Glargine safety, diabetes and cancer.Risk of bladder cancer in patients with diabetes mellitus: an updated meta-analysis of 36 observational studies.Metformin in cancer prevention and therapy.Diabetes, glucose control, glucose lowering medications, and cancer risk: a 10-year population-based historical cohort Insulin receptor isoforms A and B as well as insulin receptor substrates-1 and -2 are differentially expressed in prostate cancer.Diabetes mellitus and risk of bladder cancer: a meta-analysis of cohort studies.The effect of metformin on breast cancer outcomes in patients with type 2 diabetes A genetic polymorphism in pre-miR-27a confers clinical outcome of non-small cell lung cancer in a Chinese population.Metformin and breast and gynecological cancer risk among women with diabetes.Antiproliferative and metabolic effects of metformin in a preoperative window clinical trial for endometrial cancer.

P2860

Q21284301-8F3AF259-36E4-4A46-A147-0C7E712F7639 Q24745996-2163FA47-9518-4025-984D-492584672A64 Q26738743-3BF472A4-89B4-445C-AAB2-C071A2D4C255 Q26750845-C04AFE09-7B60-4410-A3E4-AE0FA6F62611 Q26752651-F7EF8858-BEFC-4505-9B5D-B2EE5942C7B5 Q26765139-A2B50FAF-DFDE-496D-9398-1D680A78A6E1 Q26786829-49CF5F01-8B81-44A5-8665-D616ECBDFCBD Q26801412-447C3C3D-8571-4810-984D-6A2E85F0BE72 Q26852910-F149871F-3495-4008-81D9-773B74E3B78C Q26999266-79BE14E2-2A05-44BC-A37D-555D495D70D1 Q27026813-6B8526F9-EC39-4AD7-93CB-4ECC6B011C20 Q28072665-D27D77BE-08C5-42E9-8FEE-3FB1351D30CB Q28081491-25C00F3D-A75E-4F7B-87E6-10EF839C451F Q28480735-E5F1A289-8DD7-4988-A6A6-BB9C0E629086 Q28542914-8D4E06C4-E5D3-49F7-B3FF-3B77925F92E0 Q28544009-4BE6AFD2-A995-445E-8801-266D29F293B1 Q30248629-BD500749-7FBA-4F1A-8E41-B2D53BE4A621 Q30361298-ABA4B5F1-F07D-4966-9B1D-DA204F8B278F Q33567263-C28231C8-72E1-4593-A20F-8505BAD75191 Q33607800-DD926C14-4F68-4E3C-BF86-5F28B94E9A13 Q33646542-842F1F14-C89D-4F67-995A-3B7CC1750FD1 Q33648824-E1AAC430-29B2-44A3-9883-9E08A303E332 Q33668168-678E1BF1-8D2F-4900-829C-A4876588CBE6 Q33702357-C4458598-C28D-476B-AED6-E1F611180DEA Q33714881-34DA9EFB-DC1D-46D3-BFD4-1E7CDDA48A5A Q33739341-A4F28A81-18B2-4287-8150-63A307CEFD64 Q33973037-838E784E-FCED-47F0-8DAB-837E8903A905 Q34069086-20BDB6BE-91BC-4997-A644-196CC1B2EC78 Q34135248-116A5BCA-8DDE-4DDC-938E-42BD03A1E21A Q34159241-9EF1CFFC-6A3D-42AE-AA66-DF77DD85DC27 Q34326924-ADC1130D-C86D-4DEF-83FF-130DFCFCA452 Q34353701-D3116E65-3756-47B3-AF38-6EF8150853CE Q34357983-570C44B3-382C-4D1C-A1C6-230DEC891F26 Q34392021-5D3C668D-28F8-41FD-BBE7-0E067424BFDC Q34515985-6011BFFF-12DA-4B43-90BA-1F5C38A7BAC3 Q34599224-734CBA13-2641-43E5-B971-3F853474B79C Q35000522-933FF110-DB33-4A8A-960E-799941065671 Q35040261-0609E74D-A7FA-4623-B6CC-16253536E4B8 Q35046074-E6B8EA88-415F-43C5-9274-FE6C7FBF3384 Q35084900-CE9EDD44-5F4D-44D3-8F93-19E279D51065

P2860

Mortality after incident cancer in people with and without type 2 diabetes: impact of metformin on survival

http://www.wikidata.org/entity/Q35688186

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Mortality after incident cance ...... mpact of metformin on survival

@ast

Mortality after incident cance ...... mpact of metformin on survival

@en

type

label

Mortality after incident cance ...... mpact of metformin on survival

@ast

Mortality after incident cance ...... mpact of metformin on survival

@en

prefLabel

Mortality after incident cance ...... mpact of metformin on survival

@ast

Mortality after incident cance ...... mpact of metformin on survival

@en

P1433

Q35688186-DB1D3376-D604-4DF6-83F7-7974F5F45C02

P1476

Q35688186-8707914C-311F-44DE-A395-545173CBBE58

P2093

Q35688186-3CD6BB41-4A96-42D5-B7B3-4F14B1AFABE3

Q35688186-71CB9BDF-D581-4894-BC66-C570080B4BA5

Q35688186-9A379357-152C-4427-A411-6C8B492C1892

Q35688186-DF4D3452-4B11-4147-8D58-EAAF2167C9F7

P2860

Q35688186-388AF033-6082-419C-9211-D001AD943044

Q35688186-3D6D7F7C-B946-4B46-8B44-C64BBEF9F8DB

Q35688186-6AE824D6-926E-47C6-8F79-D3E0F7B1F347

Q35688186-83A58A16-2CDA-4096-94F2-F04F1AEAF0C9

Q35688186-84AAAD1C-7BE1-413A-A7BC-478897FADAC8

Q35688186-9B05908C-46E9-4EF9-AD7A-2FFE8FEC8C51

Q35688186-A495C6AA-664B-4716-B5DD-13510545ECD7

Q35688186-AA81A84C-BA8E-4A57-B424-0389E5FE5613

Q35688186-DA924357-9F2E-4665-8D44-52D8E09C1E0B

Q35688186-F1A9137A-A417-45DF-932C-0B7B423FDBD5

P304

Q35688186-E5916FC4-0871-4084-9301-B3D6E08FF713

P31

Q35688186-5E0DF25E-9C99-45DA-98ED-168199143B65

P356

Q35688186-9F8B2261-4942-4C95-92DB-522D288A8B39

P407

Q35688186-A065FD58-1E90-4030-8CD7-F293CD01BDA0

P433

Q35688186-0EF4637D-C265-4EBA-84C3-A1D57344AFFA

P478

Q35688186-FB9259D7-1AD3-4234-92D3-81C037871FA7

P50

Q35688186-032C05EC-FB15-4556-9F1A-94F777AA8390

Q35688186-D6C2244D-F24D-4F21-A3FE-908806867619

P577

Q35688186-4320D461-7E2D-432D-A0FE-46148A856846

P5875

Q35688186-C875790E-A658-49D6-AB1A-3C5190C02405

P698

Q35688186-FD4F5BAB-CD52-435E-8E73-255096843DA1

P921

Q35688186-2D6F2F3D-ACC9-4B2B-A9F8-1B3A45CCC0A8

Q35688186-3C7A2213-7154-4051-9896-DFA97049D1DB

P932

Q35688186-D4E5E909-E923-457D-A1BE-DFC183CB529E

P356

P1433

P1476

Mortality after incident cance ...... mpact of metformin on survival

@en

P2093

Chris D Poole

http://www.w3.org/2001/XMLSchema#string

Christopher Ll Morgan

http://www.w3.org/2001/XMLSchema#string

Craig J Currie

http://www.w3.org/2001/XMLSchema#string

Edwin A M Gale

http://www.w3.org/2001/XMLSchema#string

P2860

Diabetes and cancer: a consensus report.

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

Metformin and reduced risk of cancer in diabetic patients

The association of obesity and cervical cancer screening: a systematic review and meta-analysis.

The influence of glucose-lowering therapies on cancer risk in type 2 diabetes.

Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis

Less aggressive treatment and worse overall survival in cancer patients with diabetes: a large population based analysis.

Obesity and mammography: a systematic review and meta-analysis.

New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes.

Epidemiological aspects of neoplasms in diabetes.

P304

299-304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DC11-1313

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

35

http://www.w3.org/2001/XMLSchema#string

P50

Jeffrey A Johnson

S Jenkins-Jones

P577

2012-01-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221937031

http://www.w3.org/2001/XMLSchema#string

P698

22266734

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

3263862

http://www.w3.org/2001/XMLSchema#string